+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Orthobiologics Market Size, Share & Trends Analysis Report by Product (DBM, Allograft, BMP, Viscosupplementation), Application (Spinal Fusion, Trauma Repair), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2024
  • Region: Global
  • Grand View Research
  • ID: 5976561
The global orthobiologics market size is expected to reach USD 9.3 billion by 2030, registering a CAGR of 5.5% from 2024 to 2030. Increasing cases of orthopedic surgeries across the globe is driving the demand for orthobiologics. A study presented at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) 2023, revealed that orthopedic surgeons would face a challenge in meeting the increasing demand for total joint arthroplasty (TJA). The study found that to keep up with the demand, surgeons will have to either double their TJA caseload or increase the number of surgeons by 10% every five years.

With an increasing focus on healthcare advancements and patient outcomes, governments worldwide are implementing policies and initiatives to foster the growth of orthobiologics. For instance, the American Academy of Orthopedic Surgeons (AAOS) is committed to improving musculoskeletal care in a transparent and scientific way. In October 2020, the AAOS launched the Biologics Dashboard on their website, which is designed to assist orthopedic surgeons in keeping track of the approval status of biologic-based interventions. This initiative is a part of the AAOS Biologics Initiative, which offers evidence-based guidance to the musculoskeletal health community. As part of this effort, the AAOS Board of Directors also revised two position statements related to biologics.

Increasing geriatric population across the globe is also anticipated to boost the demand for orthopedic surgeries. According to the India Ageing Report 2023, country’s elderly population is growing at a rapid pace, with a decadal growth rate of 41%. By 2050, over 20% of India's population will be elderly citizens.As people age, they are more likely to experience issues with their muscles and bones, such as osteoporosis, osteoarthritis, and fractures. This results in a greater need for orthobiologics solutions.

Moreover, increasing cases of road accidents is anticipated to supplement the market growth. According to the National Highway Traffic Safety Administration report, there were an estimated 19,515 deaths in motor vehicle accidents during the first half of 2023. This represents a decrease of about 3.3% compared to the same period in the previous year, which had 20,190 fatalities. The report also shows that fatalities decreased during both the first and second quarters of 2023. Thus, the increasing number of injured populations is expected to increase the demand for orthobiologics.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. For instance, inSeptember 2023, HippoFi Inc. partnered with Zimmer Biomet Holdings Inc. to bring forth a synthetic biomaterial for bone growth. The biomaterial will be launched under HippoFi's biologic subsidiary, PUR Biologics in 2024.

Orthobiologics Market Report Highlights

  • Based on product, the viscosupplementation segment held the largest revenue share in the market in 2023 owing to the increasing prevalence of lifestyle-related conditions and advances in hyaluronic acid therapy development
  • Based on application, the spinal fusion segment held the largest revenue share in the market in 2023 owing to the rising incidence of degenerative disc disease
  • Based on end-use, the hospitals segment accounted for the largest revenue share due to the growing patient population undergoing surgical procedures
  • North America dominated the market due to the presence of several market players and a well-established regulatory framework

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Scope
1.1.2. Regional Scope
1.1.3. Estimates and Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis (Model 1)
1.6.1.1. Approach 1: Commodity Flow Approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Application Outlook
2.2.3. End-use Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Orthobiologics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Orthobiologics: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Regulatory Framework
Chapter 4. Global Orthobiologics Market Segment Analysis, by Product, 2018-2030 (USD Billion)
4.1. Definition and Scope
4.2. Product Type Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Orthobiologics Market, by Product Type, 2018 to 2030
4.5. Demineralized Bone Matrix (DBM)
4.5.1. Demineralized Bone Matrix (DBM) Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
4.6. Allograft
4.6.1. Allograft Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
4.7. Bone Morphogenetic Protein (BMP)
4.7.1. Bone Morphogenetic Protein (BMP) Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
4.8. Viscosupplementation
4.8.1. Viscosupplementation Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
4.9. Synthetic Bone Substitutes
4.9.1. Synthetic Bone Substitutes Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
4.10. Stem Cell Therapy
4.10.1. Stem Cell Therapy Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Global Orthobiologics Market Segment Analysis, by Application, 2018-2030 (USD Billion)
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Orthobiologics Market, by Application, 2018 to 2030
5.5. Spinal Fusion
5.5.1. Spinal Fusion Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
5.6. Trauma Repair
5.6.1. Trauma Repair Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
5.7. Reconstructive Surgery
5.7.1. Reconstructive Surgery Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Global Orthobiologics Market Segment Analysis, by End-use, 2018-2030 (USD Billion)
6.1. Definition and Scope
6.2. End-use Market Share Analysis, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Orthobiologics Market, by End-use, 2018 to 2030
6.5. Hospitals
6.5.1. Hospitals Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
6.6. Outpatient Facilities
6.6.1. Outpatient Facilities Market Estimates and Forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Global Orthobiologics Market Segment Analysis, by Region, 2018-2030 (USD Billion)
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Regional Market Snapshot
7.4. Orthobiologics Market Share by Region, 2023 & 2030
7.5. North America
7.5.1. North America Orthobiologics Market, 2018-2030 (USD Billion)
7.5.2. U.S.
7.5.2.1. U.S. Orthobiologics Market, 2018-2030 (USD Billion)
7.5.3. Canada
7.5.3.1. Canada Orthobiologics Market, 2018-2030 (USD Billion)
7.6. Europe
7.6.1. Europe Orthobiologics Market, 2018-2030 (USD Billion)
7.6.2. UK
7.6.2.1. UK Orthobiologics Market, 2018-2030 (USD Billion)
7.6.3. Germany
7.6.3.1. Germany Orthobiologics Market, 2018-2030 (USD Billion)
7.6.4. France
7.6.4.1. France Orthobiologics Market, 2018-2030 (USD Billion)
7.6.5. Italy
7.6.5.1. Italy Orthobiologics Market, 2018-2030 (USD Billion)
7.6.6. Spain
7.6.6.1. Spain Orthobiologics Market, 2018-2030 (USD Billion)
7.6.7. Norway
7.6.7.1. Norway Orthobiologics Market, 2018-2030 (USD Billion)
7.6.8. Sweden
7.6.8.1. Sweden Orthobiologics Market, 2018-2030 (USD Billion)
7.6.9. Denmark
7.6.9.1. Denmark Orthobiologics Market, 2018-2030 (USD Billion)
7.7. Asia-Pacific
7.7.1. Japan
7.7.1.1. Japan Orthobiologics Market, 2018-2030 (USD Billion)
7.7.2. China
7.7.2.1. China Orthobiologics Market, 2018-2030 (USD Billion)
7.7.3. India
7.7.3.1. India Orthobiologics Market, 2018-2030 (USD Billion)
7.7.4. Australia
7.7.4.1. Australia Orthobiologics Market, 2018-2030 (USD Billion)
7.7.5. South Korea
7.7.5.1. South Korea Orthobiologics Market, 2018-2030 (USD Billion)
7.7.6. Thailand
7.7.6.1. Thailand Orthobiologics Market, 2018-2030 (USD Billion)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil Orthobiologics Market, 2018-2030 (USD Billion)
7.8.2. Mexico
7.8.2.1. Mexico Orthobiologics Market, 2018-2030 (USD Billion)
7.8.3. Argentina
7.8.3.1. Argentina Orthobiologics Market, 2018-2030 (USD Billion)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa Orthobiologics Market, 2018-2030 (USD Billion)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia Orthobiologics Market, 2018-2030 (USD Billion)
7.9.3. UAE
7.9.3.1. UAE Orthobiologics Market, 2018-2030 (USD Billion)
7.9.4. Kuwait
7.9.4.1. Kuwait Orthobiologics Market, 2018-2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. Medtronic Plc
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. DePuy Synthes
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Zimmer Biomet
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Stryker Corporation
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Bioventus LLC
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Seaspine Holdings Corporation
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Orthofix, Inc.
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Globus Medical
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Arthrex, Inc.
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Bone Biologics Corp.
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Orthobiologics Market, by Region, 2018-2030 (USD Billion)
Table 4 Global Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 5 Global Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 6 Global Orthobiologics Market, by End Use, 2018-2030 (USD Billion)
Table 7 North America Orthobiologics Market, by Region, 2018-2030 (USD Billion)
Table 8 North America Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 9 North America Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 10 North America Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 11 U.S. Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 12 U.S. Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 13 U.S. Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 14 Canada Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 15 Canada Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 16 Canada Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 17 Europe Orthobiologics Market, by Region, 2018-2030 (USD Billion)
Table 18 Europe Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 19 Europe Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 20 Europe Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 21 Germany Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 22 Germany Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 23 Germany Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 24 UK Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 25 UK Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 26 UK Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 27 France Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 28 France Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 29 France Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 30 Italy Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 31 Italy Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 32 Italy Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 33 Spain Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 34 Spain Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 35 Spain Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 36 Denmark Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 37 Denmark Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 38 Denmark Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 39 Sweden Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 40 Sweden Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 41 Sweden Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 42 Norway Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 43 Norway Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 44 Norway Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 45 Asia-Pacific Orthobiologics Market, by Region, 2018-2030 (USD Billion)
Table 46 Asia-Pacific Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 47 Asia-Pacific Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 48 Asia-Pacific Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 49 China Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 50 China Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 51 China Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 52 Japan Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 53 Japan Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 54 Japan Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 55 India Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 56 India Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 57 India Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 58 South Korea Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 59 South Korea Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 60 South Korea Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 61 Australia Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 62 Australia Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 63 Australia Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 64 Thailand Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 65 Thailand Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 66 Thailand Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 67 Latin America Orthobiologics Market, by Region, 2018-2030 (USD Billion)
Table 68 Latin America Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 69 Latin America Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 70 Latin America Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 71 Brazil Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 72 Brazil Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 73 Brazil Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 74 Mexico Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 75 Mexico Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 76 Mexico Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 77 Argentina Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 78 Argentina Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 79 Argentina Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 80 MEA Orthobiologics Market, by Region, 2018-2030 (USD Billion)
Table 81 MEA Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 82 MEA Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 83 MEA Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 84 South Africa Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 85 South Africa Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 86 South Africa Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 87 Saudi Arabia Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 88 Saudi Arabia Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 89 Saudi Arabia Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 90 UAE Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 91 UAE Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 92 UAE Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
Table 93 Kuwait Orthobiologics Market, by Product, 2018-2030 (USD Billion)
Table 94 Kuwait Orthobiologics Market, by Application, 2018-2030 (USD Billion)
Table 95 Kuwait Orthobiologics Market, by End-use, 2018-2030 (USD Billion)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 Orthobiologics Market: Outlook
Figure 9 Orthobiologics Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Orthobiologics Market Driver Impact
Figure 12 Orthobiologics Market Restraint Impact
Figure 13 Porter’s Analysis
Figure 14 PESTLE Analysis
Figure 15 Orthobiologics Market: Product Movement Analysis
Figure 16 Orthobiologics Market: Product Outlook and Key Takeaways
Figure 17 Demineralized Bone Matrix (DBM) Market Estimates and Forecast, 2018-2030
Figure 18 Allograft Estimates and Forecast, 2018-2030
Figure 19 Bone Morphogenetic Protein (BMP) Estimates and Forecast, 2018-2030
Figure 20 Viscosupplementation Estimates and Forecast, 2018-2030
Figure 21 Synthetic Bone Substitutes Estimates and Forecast, 2018-2030
Figure 22 Stem Cell Therapy Estimates and Forecast, 2018-2030
Figure 23 Orthobiologics Market: Application Movement Analysis
Figure 24 Orthobiologics Market: Application Outlook and Key Takeaways
Figure 25 Spinal Fusion Market Estimates and Forecasts, 2018-2030
Figure 26 Trauma Repair Market Estimates and Forecasts, 2018-2030
Figure 27 Reconstructive Surgery Market Estimates and Forecasts, 2018-2030
Figure 28 Orthobiologics Market: End-use Movement Analysis
Figure 29 Orthobiologics Market: End-use Outlook and Key Takeaways
Figure 30 Hospitals Market Estimates and Forecasts, 2018-2030
Figure 31 Outpatient Facilities Market Estimates and Forecasts, 2018-2030
Figure 32 Global Orthobiologics Market: Regional Movement Analysis
Figure 33 Global Orthobiologics Market: Regional Outlook and Key Takeaways
Figure 34 North America Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 35 Key Country Dynamics
Figure 36 U.S. Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 37 Key Country Dynamics
Figure 38 Canada Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 39 Europe Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 40 Key Country Dynamics
Figure 41 UK Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 42 Key Country Dynamics
Figure 43 Germany Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 44 Key Country Dynamics
Figure 45 Spain Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 46 Key Country Dynamics
Figure 47 France Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 48 Key Country Dynamics
Figure 49 Italy Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 50 Key Country Dynamics
Figure 51 Norway Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 52 Key Country Dynamics
Figure 53 Denmark Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 54 Key Country Dynamics
Figure 55 Sweden Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 56 Asia-Pacific Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 57 Key Country Dynamics
Figure 58 Japan Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 59 Key Country Dynamics
Figure 60 China Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 61 Key Country Dynamics
Figure 62 India Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 63 Key Country Dynamics
Figure 64 Australia Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 65 Key Country Dynamics
Figure 66 South Korea Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 67 Key Country Dynamics
Figure 68 Thailand Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 69 Latin America Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 70 Key Country Dynamics
Figure 71 Brazil Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 72 Key Country Dynamics
Figure 73 Mexico Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 74 Key Country Dynamics
Figure 75 Argentina Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 76 MEA Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 77 Key Country Dynamics
Figure 78 South Africa Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 79 Key Country Dynamics
Figure 80 Saudi Arabia Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 81 Key Country Dynamics
Figure 82 UAE Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 83 Key Country Dynamics
Figure 84 Kuwait Orthobiologics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 85 Key Company Categorization
Figure 86 Heat Map Analysis, 2022-2023

Companies Mentioned

  • Medtronic Plc
  • DePuy Synthes
  • Zimmer Biomet
  • Stryker Corporation
  • Bioventus LLC
  • Seaspine Holdings Corporation
  • Orthofix, Inc.
  • Globus Medical
  • Arthrex, Inc.
  • Bone Biologics Corp.

Methodology

Loading
LOADING...

Table Information